JPH09511737A - 免疫治療剤とその使用 - Google Patents
免疫治療剤とその使用Info
- Publication number
- JPH09511737A JPH09511737A JP7525497A JP52549795A JPH09511737A JP H09511737 A JPH09511737 A JP H09511737A JP 7525497 A JP7525497 A JP 7525497A JP 52549795 A JP52549795 A JP 52549795A JP H09511737 A JPH09511737 A JP H09511737A
- Authority
- JP
- Japan
- Prior art keywords
- vaccae
- tumor
- spread
- growth
- substance obtained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.腫瘍の成長乃至広がりを遅延させ或いは抑制するに有用な薬剤の製造のため に、マイコバクテリウム バッカエ(Mycobacterium vaccae)から得られる抗原 性および/または免疫調節性物質の使用。 2.M.vaccaeから得られる抗原性および/または免疫調節性物質が、M.vaccae の死滅細胞を含む請求項1による使用。 3.M.vaccaeの細胞をオートクレーブ処理により死滅させる請求項2による使 用。 4.M.vaccaeから得られる物質が、1984年2月13日付で英国 ロンドン NW9 5 HT コリンデール アベニュのナショナル コレクション オブ タイプ カル チャーズ(NCTC)セントラル パブリック ヘルス ラボラトリーに、NCTC番号 11659として寄託されている菌株から得られたものである請求項1〜3のいずれ かに記載の使用。 5.M.vaccaeから得られる物質が、単位投与量当た107〜1010個の菌を含有する 薬剤中に含まれる請求項1〜4のいずれかに記載の使用。 6.腫瘍が、乳腫瘍または気管支腫瘍である請求項1〜5のいずれかに記載の使 用。 7.腫瘍の成長乃至広がりを遅延させ或いは抑制する方 法であって、被験者に対し、マイコバクテリウム バッカエから得られる抗原性 および/または免疫調節性材料を、腫瘍の成長乃至広がりを少なくとも遅らせ或 いは防止するに十分な量で投与する方法。 8.腫瘍が、乳腫瘍である請求項7に記載の方法。 9.M.vaccaeから得られる物質が、請求項2〜5のいずれかに記載されたもの である請求項7または8に記載の方法。 10.腫瘍の成長乃至広がりを遅延させ或いは抑制するために使用される、マイ コバクテリウム バッカエから得られる物質を含有する製品。 11.M.vaccaeから得られる物質が、請求項2〜5のいずれかに記載されたも のである請求項10に記載の製品。 12.腫瘍の成長乃至広がりを遅延させ或いは抑制するための治療において使用 される、マイコバクテリウム バッカエから得られる抗原性および/または免疫 調節性物質を含有する免疫治療剤。 13.M.vaccaeから得られる物質が、請求項2〜5のいずれかに記載されたも のである請求項12に記載の治療剤。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9406301.3 | 1994-03-30 | ||
GB9406301A GB9406301D0 (en) | 1994-03-30 | 1994-03-30 | Immunotherapeutic agent and its use |
PCT/GB1995/000715 WO1995026742A1 (en) | 1994-03-30 | 1995-03-29 | Immunotherapeutic agent and its use |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH09511737A true JPH09511737A (ja) | 1997-11-25 |
JP4135190B2 JP4135190B2 (ja) | 2008-08-20 |
Family
ID=10752750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52549795A Expired - Fee Related JP4135190B2 (ja) | 1994-03-30 | 1995-03-29 | 免疫治療剤とその使用 |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0752870B1 (ja) |
JP (1) | JP4135190B2 (ja) |
KR (1) | KR100392582B1 (ja) |
CN (1) | CN1121874C (ja) |
AP (1) | AP9600861A0 (ja) |
AT (1) | ATE218355T1 (ja) |
AU (1) | AU699081B2 (ja) |
BR (1) | BR9507338A (ja) |
CA (1) | CA2186851C (ja) |
CZ (1) | CZ280196A3 (ja) |
DE (1) | DE69526935T2 (ja) |
DK (1) | DK0752870T3 (ja) |
ES (1) | ES2177638T3 (ja) |
FI (1) | FI111223B (ja) |
GB (1) | GB9406301D0 (ja) |
HU (1) | HU220858B1 (ja) |
NO (1) | NO964075L (ja) |
NZ (1) | NZ282863A (ja) |
PT (1) | PT752870E (ja) |
RU (1) | RU2139728C1 (ja) |
WO (1) | WO1995026742A1 (ja) |
ZA (1) | ZA952644B (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005528332A (ja) * | 2001-12-10 | 2005-09-22 | カーマー,バクレシュ,マファトラル | 癌を治療する方法 |
JP2012097112A (ja) * | 2004-06-07 | 2012-05-24 | Qu Biologics Inc | 癌を治療するための細菌組成物 |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5985287A (en) * | 1996-08-29 | 1999-11-16 | Genesis Research And Development Corporation Limited | Compounds and methods for treatment and diagnosis of mycobacterial infections |
US6284255B1 (en) * | 1996-08-29 | 2001-09-04 | Genesis Research & Development Corporation Limited | Compounds and methods for treatment and diagnosis of mycobacterial infections |
US6160093A (en) * | 1996-08-29 | 2000-12-12 | Genesis Researth And Development Corporation Limited | Compounds and methods for treatment and diagnosis of mycobacterial infections |
US6406704B1 (en) | 1996-08-29 | 2002-06-18 | Genesis Research And Development Corporation Limited | Compounds and methods for treatment and diagnosis of mycobacterial infections |
US6878377B2 (en) | 1996-12-18 | 2005-04-12 | Stanford Rook Limited | Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system |
DK0951289T3 (da) * | 1996-12-18 | 2006-03-13 | Stanford Rook Ltd | Anvendelse af Mycobacterium vaccae til behandling af kronisk træthedssyndrom |
US6328978B1 (en) | 1997-12-23 | 2001-12-11 | Genesis Research & Development Corp. Ltd. | Methods for the treatment of immunologically-mediated skin disorders |
US5968524A (en) * | 1997-12-23 | 1999-10-19 | Genesis Research & Development Corp. | Methods and compounds for the treatment of immunologically-mediated psoriasis |
US6350457B1 (en) | 1999-06-02 | 2002-02-26 | Genesis Research & Development Corporation Limited | Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
WO2003063896A1 (en) * | 2002-01-29 | 2003-08-07 | Modi, Rajiv, Indravadan | Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals |
US9107864B2 (en) | 2004-06-07 | 2015-08-18 | Qu Biologics Inc. | Tissue targeted antigenic activation of the immune response to treat cancers |
US8501198B2 (en) | 2004-06-07 | 2013-08-06 | Qu Biologics Inc. | Tissue targeted antigenic activation of the immune response to treat cancers |
US8034359B2 (en) | 2004-06-07 | 2011-10-11 | Qu Biologics Inc. | Tissue targeted antigenic activation of the immune response to cancers |
BG66067B1 (bg) * | 2005-05-18 | 2011-01-31 | Спартак ХАДЖИЕВ | Средство с антитуморна активност на база бцж ваксина, метод за неговото получаване и използването му |
WO2007112316A2 (en) | 2006-03-24 | 2007-10-04 | Morton Donald L | Mycobacterial immunotherapy for cancer treatment |
US8980279B2 (en) | 2010-07-26 | 2015-03-17 | Qu Biologics | Personalized site-specific immunomodulation |
CN103140238B (zh) | 2010-07-26 | 2016-03-16 | Qu生物制药公司 | 免疫原性抗炎组合物 |
RU2020120075A (ru) | 2014-05-02 | 2020-07-03 | Кью Байолоджикс Инк. | Противомикробная иммуномодуляция |
CA2990107A1 (en) * | 2015-06-24 | 2016-12-29 | Immodulon Therapeutics Limited | A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8919321D0 (en) * | 1989-08-25 | 1989-10-11 | Univ London | Treatment of chronic inflammatory conditions |
GB9203814D0 (en) * | 1992-02-21 | 1992-04-08 | Univ London | Treatment of long term auto-immune conditions |
-
1994
- 1994-03-30 GB GB9406301A patent/GB9406301D0/en active Pending
-
1995
- 1995-03-29 CA CA002186851A patent/CA2186851C/en not_active Expired - Fee Related
- 1995-03-29 WO PCT/GB1995/000715 patent/WO1995026742A1/en active IP Right Grant
- 1995-03-29 NZ NZ282863A patent/NZ282863A/en not_active IP Right Cessation
- 1995-03-29 JP JP52549795A patent/JP4135190B2/ja not_active Expired - Fee Related
- 1995-03-29 KR KR1019960705485A patent/KR100392582B1/ko not_active IP Right Cessation
- 1995-03-29 CN CN95193357A patent/CN1121874C/zh not_active Expired - Fee Related
- 1995-03-29 HU HU9602661A patent/HU220858B1/hu not_active IP Right Cessation
- 1995-03-29 AP APAP/P/1996/000861A patent/AP9600861A0/en unknown
- 1995-03-29 ES ES95913247T patent/ES2177638T3/es not_active Expired - Lifetime
- 1995-03-29 PT PT95913247T patent/PT752870E/pt unknown
- 1995-03-29 EP EP95913247A patent/EP0752870B1/en not_active Expired - Lifetime
- 1995-03-29 AU AU20785/95A patent/AU699081B2/en not_active Ceased
- 1995-03-29 RU RU96119793A patent/RU2139728C1/ru not_active IP Right Cessation
- 1995-03-29 DK DK95913247T patent/DK0752870T3/da active
- 1995-03-29 BR BR9507338A patent/BR9507338A/pt not_active Application Discontinuation
- 1995-03-29 AT AT95913247T patent/ATE218355T1/de not_active IP Right Cessation
- 1995-03-29 DE DE69526935T patent/DE69526935T2/de not_active Expired - Lifetime
- 1995-03-29 CZ CZ962801A patent/CZ280196A3/cs unknown
- 1995-03-30 ZA ZA952644A patent/ZA952644B/xx unknown
-
1996
- 1996-09-27 FI FI963866A patent/FI111223B/fi not_active IP Right Cessation
- 1996-09-27 NO NO964075A patent/NO964075L/no not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005528332A (ja) * | 2001-12-10 | 2005-09-22 | カーマー,バクレシュ,マファトラル | 癌を治療する方法 |
JP2012097112A (ja) * | 2004-06-07 | 2012-05-24 | Qu Biologics Inc | 癌を治療するための細菌組成物 |
Also Published As
Publication number | Publication date |
---|---|
ES2177638T3 (es) | 2002-12-16 |
DK0752870T3 (da) | 2002-07-15 |
MX9604401A (es) | 1997-12-31 |
AU699081B2 (en) | 1998-11-19 |
NZ282863A (en) | 2001-06-29 |
GB9406301D0 (en) | 1994-05-25 |
KR970702057A (ko) | 1997-05-13 |
FI111223B (fi) | 2003-06-30 |
FI963866A (fi) | 1996-09-27 |
CZ280196A3 (en) | 1997-02-12 |
CN1150388A (zh) | 1997-05-21 |
RU2139728C1 (ru) | 1999-10-20 |
JP4135190B2 (ja) | 2008-08-20 |
CN1121874C (zh) | 2003-09-24 |
CA2186851C (en) | 2008-11-18 |
EP0752870B1 (en) | 2002-06-05 |
HU220858B1 (en) | 2002-06-29 |
DE69526935T2 (de) | 2002-09-19 |
AP9600861A0 (en) | 1996-10-31 |
AU2078595A (en) | 1995-10-23 |
DE69526935D1 (de) | 2002-07-11 |
NO964075D0 (no) | 1996-09-27 |
FI963866A0 (fi) | 1996-09-27 |
HUT75835A (en) | 1997-05-28 |
CA2186851A1 (en) | 1995-10-12 |
KR100392582B1 (ko) | 2003-10-30 |
ATE218355T1 (de) | 2002-06-15 |
NO964075L (no) | 1996-11-25 |
BR9507338A (pt) | 1997-09-16 |
WO1995026742A1 (en) | 1995-10-12 |
ZA952644B (en) | 1996-01-11 |
HU9602661D0 (en) | 1996-11-28 |
PT752870E (pt) | 2002-09-30 |
EP0752870A1 (en) | 1997-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4135190B2 (ja) | 免疫治療剤とその使用 | |
DE60032622T2 (de) | Zusammensetzung und verfahren zur krebs-antigen-immuntherapie | |
Salvin et al. | Brief communication: tumor suppression by a lymphokine released into the circulation of mice with delayed hypersensitivity | |
JP2019515005A (ja) | 水酸化アルミニウムゲル−塩化ナトリウム複合免疫学的アジュバント、並びにその調製方法及びその使用 | |
UA79952C2 (en) | MYCOBACTERIUM w APPLICATIONS FOR CANCER TREATMENT | |
US6056964A (en) | Immunotherapeutic agent and its use | |
US6726913B1 (en) | Treatment of dermal tumors, warts, and viral infections of the respiratory tract in humans using heat-killed P. acnes | |
AU4338189A (en) | Immunotherapy vaccine for melanoma tumors | |
EP1154792A2 (en) | Tuberculosis vaccine formulation comprising monoglycerides or fatty acids as adjuvant | |
Mitchell | Attempts to optimize active specific immunotherapy for melanoma | |
Chen et al. | Immunization against" Brucella" Infections: Immune Response of Mice, Guinea pigs, and Cynomolgus philipinensis to Live and Killed Brucella melitensis Strain Rev. I Administered by Various Methods | |
CA2383626A1 (en) | Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes | |
JPH11512076A (ja) | Adp−リボシルトランスフェラーゼ活性を呈する組成物、及びその調製及び使用のための方法 | |
Weiss | Antituberculous vaccination in the guinea pig with non-living vaccines | |
Halle-Pannenko et al. | Comparison of various BCG preparations in the EORTC—ICIG experimental screening for systemic immunity adjuvants applicable to cancer immunotherapy | |
JP2001010961A (ja) | 腫瘍ワクチン | |
US6596282B1 (en) | Treatment of chronic viral infections with M. vaccae | |
MXPA96004401A (es) | Agente inmunoterapeutico y su uso | |
Barber et al. | Immunotherapy and immunopotentiation | |
JPH03109331A (ja) | 腫瘍壊死因子効果増強剤 | |
Baogang et al. | Fixed-tumor vaccine: a practical formulation with cytokine-microspheres for protective and therapeutic antitumor immunity | |
McCune | Cytokines as Possible Adjuvants to Vaccines in Active Specific Immunotherapy for Renal Cell Carcinoma | |
Maugh et al. | Immunotherapy: New Strategies for Cancer Therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060328 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060627 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070710 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071102 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20071210 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20080131 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080430 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080526 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110613 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110613 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120613 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130613 Year of fee payment: 5 |
|
LAPS | Cancellation because of no payment of annual fees |